Piscataway, N.J. Mar. 4, 2025 — HORIBA, a global leader in analytical and measurement technology, is proud to announce an expanded portfolio of instruments tailored to meet the rigorous demands of the pharmaceutical industry. HORIBA’s current suite of offerings encompasses applications across the entire pharmaceutical lifecycle—from drug discovery and development to manufacturing and quality control.
HORIBA’s technologies are designed to meet the rigorous demands of pharmaceutical processes, to ensure precision, efficiency, and compliance. The newly enhanced portfolio supports key applications such as:
- Cell Culture Media Analysis: Accurate monitoring of cell culture environments to optimize biopharmaceutical production.
- Vaccine Development: Advanced analytical tools for formulation and quality control to streamline vaccine research, manufacturing, and QA/QC.
- Protein and Biomolecule Characterization: Precise measurement and analysis of molecular interactions critical for therapeutic development.
- Particle Size and Morphology: Understanding and ensuring dynamics, consistency, and quality in pharmaceutical formulations.
- Contaminant Detection: Safeguarding the integrity of drug products by identifying and quantifying impurities.
HORIBA is launching two new products at Pittcon to complement the current suite:
- The new Veloci™ A-TEEM BioPharma Analyzer is a unique solution for the biopharma and pharma industries that combines the selectivity of chromatography with the advantages of optical spectroscopy. This technology provides a fast, cost-effective, and user-friendly approach to component analysis and eliminates the need for traditional column-based separations.
Veloci utilizes label-free intrinsic fluorescence analysis, providing unprecedented precision and efficiency over a wide range of applications, including monoclonal antibody discrimination, cell media monitoring, vaccine characterization, protein stability analysis, and adeno-associated virus (AAV) quantification.
- The PoliSpectra Rapid Raman Plate Reader is a high-throughput Raman screening tool designed for the pharmaceutical industry that uses Raman spectroscopy to measure 96 wells in one minute. The RPR’s non-destructive sampling enables live reaction monitoring, and formulation optimization, providing high spectral quality for in-depth characterization.
These two new instruments complement HORIBA’s line of solutions for the biopharma and pharma industries, including:
- MacroRAM: High-performance Raman spectroscopy for material identification and quality assurance.
- Raman Multi-stream Analyzer: Raman spectroscopy enables in situ monitoring of key concentrations for nutrients, metabolites, and byproducts, such as glucose, lactate, and ammonia.
- Partica: Versatile particle size analyzer for particle size distribution analysis of powders, suspensions, and emulsions.
- ViewSizer: A dynamic tool for nanoparticle tracking and characterization to understand complex particle behaviors.
“The pharmaceutical industry is evolving rapidly, and HORIBA is committed to empowering the pharmaceutical industry with innovative analytical tools and fully engineered solutions that accelerate research, enhance quality, and streamline production,” Andrew Whitley, Vice President and Field Officer for the HORIBA Life Science Business Field, said. “Our expanded portfolio reflects our dedication to supporting breakthroughs from the lab to the production line for pharmaceutical professionals worldwide.”
About HORIBA
Founded in 1953, HORIBA has explored a wide range of unique measurement and analysis technologies to meet global customer needs from 47 group companies and local sites spread across 28 countries and regions. Under the corporate motto Joy and Fun, the company has expanded and refined its core technologies to solve society’s energy issues of today and tomorrow. Our unique measurement and analysis technologies are valued in various fields of society including the three megatrend business fields of Energy & Environment, Biology & Healthcare and Materials & Semiconductor. For more information on HORIBA, visit https://www.horiba.com/int/company/about-horiba/home/
For more information about HORIBA’s pharmaceutical solutions, please visit https://www.horiba.com/usa/applications/life-science/biopharma-and-pharma/
Media Contact:
Joanne Lowy
HORIBA
Senior Marketing Specialist
joanne.lowy@horiba.com
732-600-2569
